moxifloxacin + artificial tears + dexamethasone + fluorometholone

This conventional treatment regimen was utilized as the control arm in a clinical study sponsored by Benha University to evaluate corneal epithelial healing following photorefractive keratectomy (PRK). The regimen includes the topical fluoroquinolone antibiotic moxifloxacin (0.5%) to prevent post-operative infection, artificial tears (Systane Ultra) for ocular surface lubrication and hydration, and a sequential corticosteroid protocol involving dexamethasone (0.1%) followed by fluorometholone (0.1%) to manage inflammation and prevent corneal haze. This combination represents the standard of care against which experimental therapies like topical insulin and autologous serum were compared.

Brand names

VigamoxSystane UltraMaxidexEfemyo

Other names

Conventional treatment